Biomadvanced Diagnostics is a series a startup based in France. 2 investors tracked.
Based in France, Biomadvanced Diagnostics is a startup founded in 2022. Its most recent tracked round is Series A. Brouky records 2 investors associated with the company.
Biomadvanced Diagnostics is a MedTech startup focused on biomarker discovery and personalized medicine, offering diagnostic tests that identify biomarkers to evaluate and predict transplant rejection risks, aiding clinicians in personalizing treatment for transplant patients.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.